House holds hearing on legislation to reauthorize, build on SUPPORT Act
The House Energy and Commerce Subcommittee on Health today held a hearing on legislation to reauthorize and build on the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act of 2018. AHA last week shared with the subcommittee its recommendations, which range from eliminating the Medicaid exclusion for Institutions of Mental Disease and the 190-day lifetime limit on Medicare coverage for psychiatric hospital care to bolstering reimbursement and reducing regulatory burdens for behavioral health providers to strengthening the health care workforce.
Related News Articles
Headline
The Centers for Disease Control and Prevention Aug. 5 announced a new campaign educating youth ages 12-17 on substance use, mental health and how they are…
Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Headline
The AHA released a new toolkit to improve continuity of care for patients with opioid and stimulant use disorders. Developed with support from the Centers for…
Headline
The Substance Abuse and Mental Health Services Administration July 28 released its latest national survey on drug use and mental health. Among the findings,…
Headline
The U.S. Department of Health and Human Services July 10 rescinded a policy that extended certain federal public benefits to immigrants lacking permanent legal…
Headline
The House June 4 passed the AHA-supported SUPPORT Act (H.R. 2483) by a 366-57 vote. The legislation reauthorizes key prevention, treatment and recovery…